{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T11:12:11Z","timestamp":1788606731437,"version":"build-2803163510"},"reference-count":42,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["RS-2024-00442464"],"award-info":[{"award-number":["RS-2024-00442464"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Densitometry"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jocd.2026.101714","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T23:32:48Z","timestamp":1778196768000},"page":"101714","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Erxian decoction for postmenopausal osteoporosis: An updated systematic review and meta-analysis"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-5511-9404","authenticated-orcid":false,"given":"Jiho","family":"Pyun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manki","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taekyu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sungeun","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoonchul","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changsub","family":"Yeum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunbin","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0627-768X","authenticated-orcid":false,"given":"Seung-Hun","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.jocd.2026.101714_bib0001","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1007\/s00198-022-06454-3","article-title":"Global, regional prevalence, and risk factors of osteoporosis according to the World Health Organization diagnostic criteria: a systematic review and meta-analysis","volume":"33","author":"Xiao","year":"2022","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jocd.2026.101714_bib0002","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.882241","article-title":"The global burden of osteoporosis, low bone mass, and its related fracture in 204 countries and Territories, 1990-2019","volume":"13","author":"Shen","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"10.1016\/j.jocd.2026.101714_bib0003","doi-asserted-by":"crossref","first-page":"166","DOI":"10.5312\/wjo.v10.i3.166","article-title":"Changing trends in the mortality rate at 1-year post hip fracture - a systematic review","volume":"10","author":"Downey","year":"2019","journal-title":"World J Orthop"},{"issue":"2","key":"10.1016\/j.jocd.2026.101714_bib0004","doi-asserted-by":"crossref","first-page":"224","DOI":"10.7326\/M22-1034","article-title":"Pharmacologic treatment of primary osteoporosis or low bone mass to prevent fractures in adults: a living clinical guideline from the American College of Physicians","volume":"176","author":"Qaseem","year":"2023","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.jocd.2026.101714_bib0006","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1097\/AOG.0000000000004730","article-title":"Management of postmenopausal osteoporosis: ACOG Clinical Practice Guideline No. 2","volume":"139","year":"2022","journal-title":"Obs Gynecol"},{"issue":"9","key":"10.1016\/j.jocd.2026.101714_bib0007","doi-asserted-by":"crossref","first-page":"660","DOI":"10.5312\/wjo.v12.i9.660","article-title":"Current concepts in the management of bisphosphonate associated atypical femoral fractures","volume":"12","author":"Rudran","year":"2021","journal-title":"World J Orthop"},{"issue":"2","key":"10.1016\/j.jocd.2026.101714_bib0008","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4103\/2231-0762.178742","article-title":"Medication-related osteonecrosis of the jaw: clinical and practical guidelines","volume":"6","author":"Rosella","year":"2016","journal-title":"J Int Soc Prev Community Dent"},{"issue":"7","key":"10.1016\/j.jocd.2026.101714_bib0009","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S0025-6196(11)60752-0","article-title":"Adverse effects of bisphosphonates: implications for osteoporosis management","volume":"84","author":"Kennel","year":"2009","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jocd.2026.101714_bib0010","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1063899","article-title":"Kidney tonifying traditional Chinese medicine: potential implications for the prevention and treatment of osteoporosis","volume":"13","author":"Duan","year":"2023","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jocd.2026.101714_bib0011","doi-asserted-by":"crossref","unstructured":"Chen J., Zheng J., Chen M., Lin S., Lin Z. 2021 The efficacy and safety of Chinese herbal medicine Xianling Gubao Capsule combined with alendronate in the treatment of primary osteoporosis: a systematic review and meta-analysis of 20 randomized controlled trials. 12:695832.","DOI":"10.3389\/fphar.2021.695832"},{"issue":"42","key":"10.1016\/j.jocd.2026.101714_bib0012","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000034773","article-title":"Mechanism of Liuwei Dihuang Pills in treating osteoporosis based on network pharmacology","volume":"102","author":"Wang","year":"2023","journal-title":"Med (Baltim)"},{"key":"10.1016\/j.jocd.2026.101714_bib0013","article-title":"Analysis of molecular mechanism of erxian decoction in treating osteoporosis based on formula optimization model","author":"Yang","year":"2021","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.jocd.2026.101714_bib0014","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2147\/CIA.S117597","article-title":"Effects of Chinese herbal formula Erxian decoction for treating osteoporosis: a systematic review","volume":"12","author":"Li","year":"2017","journal-title":"Clin Interv Aging"},{"key":"10.1016\/j.jocd.2026.101714_bib0015","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.jocd.2026.101714_bib0016","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.jocd.2026.101714_bib0017","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d4002","article-title":"Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials","volume":"343","author":"Sterne","year":"2011","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.jocd.2026.101714_bib0018","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1046\/J.1524-4733.2002.55150.x","article-title":"Odds ratio, relative risk, absolute risk reduction, and the number needed to treat\u2013which of these should we use?","volume":"5","author":"Schechtman","year":"2002","journal-title":"Value Health"},{"key":"10.1016\/j.jocd.2026.101714_bib0019","series-title":"Cochrane Handbook for Systematic Reviews of Interventions version 6.5 (updated August 2024)","author":"Higgins","year":"2024"},{"issue":"6","key":"10.1016\/j.jocd.2026.101714_bib0023","first-page":"1222","article-title":"Treatment in winter of postmenopausal osteoporosis with traditional Chinese medicine which invigorate kidney and essence replenishment","volume":"32","author":"Cai","year":"2016","journal-title":"J Chang Univ Chin Med"},{"issue":"1","key":"10.1016\/j.jocd.2026.101714_bib0024","first-page":"74","article-title":"Observation of the efficacy of modified erxian decoction in treating postmenopausal osteoporosis and its impact on patients' E2 and ALP levels","volume":"23","author":"Xu","year":"2016","journal-title":"Chin J Tradit Med Sci Technol"},{"issue":"6","key":"10.1016\/j.jocd.2026.101714_bib0025","first-page":"23","article-title":"Clinical study on erxian decoction combined with Elcatonin in the treatment of postmenopausal osteoporosis","volume":"23","author":"Ye","year":"2016","journal-title":"Chin J Inf Tradit Chin Med"},{"issue":"17","key":"10.1016\/j.jocd.2026.101714_bib0026","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4103\/0366-6999.196567","article-title":"Clinical observation on treating osteoporosis after menopause with the erxian decoction plus alendronate-dimensional D3","volume":"9","author":"Chen","year":"2017","journal-title":"Clin J Chin Med"},{"issue":"9","key":"10.1016\/j.jocd.2026.101714_bib0027","first-page":"2109","article-title":"Research on effect of taking Chinese herbs with kidney nourishment in winter on bone resorption for patients with postmenopausal osteoporosis","volume":"12","author":"Li","year":"2017","journal-title":"World Chin Med"},{"issue":"09","key":"10.1016\/j.jocd.2026.101714_bib0028","first-page":"150","article-title":"Clinical study of modified erxian decoction combined with alendronate for postmenopausal osteoporosis patients","volume":"36","author":"Zhang","year":"2018","journal-title":"J Sichuan Tradit Chin Med"},{"issue":"2","key":"10.1016\/j.jocd.2026.101714_bib0029","first-page":"139","article-title":"The effect of the treatment in winter and summer on estradiol and melatonin level for postmenopausal osteoporosis with traditional Chinese medicine which invigorate the kidney and essence replenishment","volume":"38","author":"Cai","year":"2019","journal-title":"J Tianjin Univ Tradit Chin Med"},{"issue":"14","key":"10.1016\/j.jocd.2026.101714_bib0034","first-page":"132","article-title":"Exploration of the effectiveness of erxian decoction in treating postmenopausal osteoporosis with","volume":"20","author":"Chen","year":"2025","journal-title":"Kidney Yang Defic Impact Bone Density"},{"issue":"8","key":"10.1016\/j.jocd.2026.101714_bib0020","first-page":"886","article-title":"The clinical observation of modified erxian decoction for postmenopausal osteoporosis","volume":"18","author":"Liu","year":"2012","journal-title":"Chin J Basic Med Tradit Chin Med"},{"issue":"12","key":"10.1016\/j.jocd.2026.101714_bib0021","first-page":"2806","article-title":"Efficacy of salmon calcitonin plus erxian decoction (EXD) for osteoporosis in postmenopausal women:a clinical observation","volume":"30","author":"Zhu","year":"2012","journal-title":"Chin Arch Tradit Chin Med"},{"issue":"03","key":"10.1016\/j.jocd.2026.101714_bib0030","first-page":"199","article-title":"Clinical observation of erxian decoction in the treatment of postmenopausal osteoporosis","volume":"22","author":"Ju","year":"2020","journal-title":"J Liaoning Univ Tradit Chin Med"},{"issue":"27","key":"10.1016\/j.jocd.2026.101714_bib0022","first-page":"2569","article-title":"Observation of 35 therapeutic efficacy of modified erxian decoction for postmenopausal osteoporosis","volume":"25","author":"Jiang","year":"2014","journal-title":"China Pharm"},{"issue":"01","key":"10.1016\/j.jocd.2026.101714_bib0031","first-page":"30","article-title":"Effect of Jiawei Erxian decoction combined with Caltrate D on bone mineral density,bone metabolism markers and visual analogue scale (VAS) in postmenopausal osteoporosis patients","volume":"28","author":"Chen","year":"2021","journal-title":"Pharm Biotechnol"},{"issue":"03","key":"10.1016\/j.jocd.2026.101714_bib0032","first-page":"8","article-title":"Applied values and mechanism of action of oral application of Erxian Tang in treatment of postmenopausal osteoporosis with syndrome of kidney-yang deficiency: a clinical study","volume":"34","author":"Wang","year":"2022","journal-title":"J Tradit Chin Orthop Traumatol"},{"issue":"08","key":"10.1016\/j.jocd.2026.101714_bib0033","first-page":"1511","article-title":"Clinical study on the adjuvant treatment of osteoporosis with erxian decoction","volume":"40","author":"Wang","year":"2024","journal-title":"J Pract Tradit Chin Med"},{"key":"10.1016\/j.jocd.2026.101714_bib0035","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jep.2019.01.010","article-title":"Erxian decoction, a Chinese herbal formula, for menopausal syndrome: an updated systematic review","volume":"234","author":"Wang","year":"2019","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.jocd.2026.101714_bib0036","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13020-015-0051-z","article-title":"Network pharmacological identification of active compounds and potential actions of erxian decoction in alleviating menopause-related symptoms","volume":"10","author":"Wang","year":"2015","journal-title":"Chin Med"},{"key":"10.1016\/j.jocd.2026.101714_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2025.119702","article-title":"Integrating metabolomics and network pharmacology to study the mechanism of Er-Xian decoction in improving intervertebral disc degeneration","volume":"346","author":"Wang","year":"2025","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.jocd.2026.101714_bib0038","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1377079","article-title":"Therapeutic potential of erxian decoction and its special chemical markers in depression: a review of clinical and preclinical studies","volume":"15","author":"Zeng","year":"2024","journal-title":"Front Pharmacol"},{"issue":"4","key":"10.1016\/j.jocd.2026.101714_bib0039","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1177\/1534735412464519","article-title":"An in vitro and in vivo investigation of the antimetastatic effects of a Chinese medicinal decoction, erxian decoction, on human ovarian cancer models","volume":"12","author":"Chu","year":"2013","journal-title":"Integr Cancer Ther"},{"issue":"1","key":"10.1016\/j.jocd.2026.101714_bib0040","doi-asserted-by":"crossref","DOI":"10.1002\/jgm.3617","article-title":"Erxian decoction-induced serum exosomes slowed bone marrow mesenchymal stem cell senescence through mitophagy","volume":"26","author":"Huang","year":"2024","journal-title":"J Gene Med"},{"key":"10.1016\/j.jocd.2026.101714_bib0041","doi-asserted-by":"crossref","first-page":"988","DOI":"10.3389\/fphar.2019.00988","article-title":"Erxian decoction attenuates TNF-\u03b1 induced osteoblast apoptosis by modulating the akt\/Nrf2\/HO-1 signaling pathway","volume":"10","author":"Wang","year":"2019","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jocd.2026.101714_bib0042","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s44424-025-00012-4","article-title":"Effects of Gamisoyo-San, a traditional herbal medicine, on antioxidant phase II enzymes via Akt-Erk-Nrf2 pathway","volume":"18","author":"Bae","year":"2025","journal-title":"Innov Acupunct Med"},{"key":"10.1016\/j.jocd.2026.101714_bib0043","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2022.115835","article-title":"Er-Xian decoction attenuates ovariectomy-induced osteoporosis by modulating fatty acid metabolism and IGF1\/PI3K\/AKT signaling pathway","volume":"301","author":"Ma","year":"2023","journal-title":"J Ethnopharmacol"}],"container-title":["Journal of Clinical Densitometry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109469502600048X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109469502600048X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T10:39:46Z","timestamp":1788604786000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S109469502600048X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S109469502600048X"],"URL":"https:\/\/doi.org\/10.1016\/j.jocd.2026.101714","relation":{},"ISSN":["1094-6950"],"issn-type":[{"value":"1094-6950","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Erxian decoction for postmenopausal osteoporosis: An updated systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Densitometry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocd.2026.101714","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The International Society for Clinical Densitometry. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101714"}}